Anika Therapeutics
Anika’s osteoarthritis pain drug falls short at Phase 3
June 21, 2018Research and Development Anika Therapeutics, Cingal, osteoarthritis, pharma
Anika Therapeutics has become the latest in a recent string of firms to suffer a failure in a late-stage trial, …
Anika Therapeutics names CMO, COO
April 4, 2016Sales and Marketing Anika Therapeutics, CMO, COO, Executive appointment
Anika Therapeutics (Nasdaq: ANIK) on Monday named the executive appointments of Stephen Mascioli the chief medical officer (CMO) and Dana …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
